Vyndamax
- Brands Vyndamax
- Product Code: Vyndamax
Vyndamax (tafamidis meglumine) is a prescription drug indicated for the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), a rare and progressive condition caused by the buildup of misfolded transthyretin proteins in the heart. Vyndamax works by selectively binding to and stabilizing the transthyretin tetramer, preventing its dissociation into amyloidogenic monomers that form harmful deposits in heart tissue. Taken orally once daily, Vyndamax helps slow the progression of the disease, improving patient quality of life and reducing hospitalizations related to heart failure. Patients should use this medication under medical supervision and report any side effects such as urinary tract infections, diarrhea, or fatigue.
- Availability: In Stock
American Diabetes Association
Diabetes Disaster_Response Coalition storing insulin
FDA Approved Prescription